Karyopharm Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Karyopharm Therapeutics Inc. (KPTI) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.88 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-13
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.88M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.49M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.82M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.72M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.88M 10-K · filed 2026-02-13 |
| 2024-12-31 | $1.49M 10-K · filed 2025-02-19 |
| 2023-12-31 | $3.82M 10-K · filed 2024-02-29 |
| 2022-12-31 | $3.72M 10-K · filed 2023-02-17 |
| 2021-12-31 | $3.45M 10-K · filed 2022-03-01 |
| 2020-12-31 | $3.28M 10-K · filed 2021-02-24 |
| 2019-12-31 | $3.20M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |